Home > News > Recent cases

Recent cases

EasyGroup v Nuclei [2023] EWCA Civ 124727 October 2023Jaani Riordan appeared for the successful Respondents (“Nuclei”) in an appeal brought by easyGroup Ltd (“easyGroup”) against a decision of Bacon J dismissing its claims for infringement of four trade marks for “easyOffice” and related devices (“the Marks”) and revoking all four Marks for non-use. easyGroup alleged infringement under ss 10(1) and 10(2) of the […]
Philip Morris v Nicoventures [2023] EWHC 2616 (Pat)25 October 2023Andrew Lykiardopoulos KC appeared for the successful claimants (together “PMI”) in a patent validity action brought against the defendants (together “BAT”). PMI sought to revoke BAT’s patent (“the Patent”) on grounds of: (i) anticipation; (ii) obviousness; (iii) added matter (in light of BAT’s conditional amendments), and sought an Arrow declaration. BAT counterclaimed for infringement. The […]
EnOcean v Far Eastern & TLC [2023] EWHC 2615 (IPEC)24 October 2023Michael Conway appeared for the Claimant and Jonathan Hill appeared for the Defendants in a patent infringement and validity action. Only validity was in issue, as the Defendants accepted that their product, the Quinetic Wireless Switch, fell within two claims of the Claimant’s patent (“the Patent”). The Defendants counterclaimed for revocation of the Patent on […]
Abbott Diabetes v Dexcom [2023] EWHC 2591 (Ch)18 October 2023Daniel Alexander KC, James Whyte and Jennifer Dixon appeared for the claimant (“Abbott”) against the defendant (“Dexcom”), in the third trial in a series of patent infringement trials concerning continuous glucose monitoring (“CGM”) systems. Dexcom sought to revoke Abbott’s patent (the “Patent”) on grounds of: (i) added matter; (ii) insufficiency; (iii) anticipation; and (iv) obviousness. […]
Astellas Pharma v Teva Pharmaceutical [2023] EWHC 2571 (Pat)17 October 2023Charlotte May KC appeared on behalf of two sets of defendants (“Teva” and “Sandoz”) in patent infringement proceedings brought by the claimant (“Astellas”). Teva and Sandoz sought to revoke the patent on grounds of: (i) insufficiency; (ii) obviousness; and (iii) added matter. The patent related to a modified release (“MR”) formulation for a drug, mirabegron, […]
Chiaro Technology v Mayborn [2023] EWHC 2417 (Pat)5 October 2023Lindsay Lane KC appeared on behalf of the Claimant (“Chiaro”) in proceedings brought against the Defendant (“Mayborn”) for infringement of three of Chiaro’s registered designs. The three designs had been incorporated into the same product, namely a wearable breast pump for nursing mothers. Mayborn’s allegedly infringing product was a competing wearable breast pump. The judge, […]
Prysmian Cables v M/S Apple [2023] EWHC 2176 (IPEC)7 September 20237 September 2023 Maxwell Keay represented the Claimant “Prysmian” as sole counsel in a trade mark infringement and passing off claim against the Defendants for use of a logo containing “BICC Components” (the “Logo”) in relation to cable accessories, and a claim for a declaration of invalidity of the Second Defendant’s trade mark for the […]
Nokia v Oneplus [2023] EWHC 1912 (Pat)26 July 2023Andrew Lykiardopoulos KC (together with Kassie Smith KC and Ravi Mehta) represented the Defendants “Oppo” and Thomas Jones (led by Sarah Ford KC) represented the Claimants “Nokia” in a trial to determine the approach to FRAND licensing following a finding of infringement of a valid Standard Essential Patent in the UK,  where there are corresponding […]
Sky UK Ltd v British Telecommunications Plc [2023] EWHC 2252 (Ch)25 July 2023Jaani Riordan and Henry Edwards represented the Applicant, Sky UK, in an application for a novel form of website blocking injunction against the six largest UK Internet Service Providers (“ISPs”).  The order was sought under Section 97A of the of the Copyright, Designs and Patents Act 1988 and was the first to tackle broadcast channel […]
Teva Pharmaceutical v Grunenthal [2023] EWHC 1836 (Pat)24 July 2023Charlotte May KC (together with Joe Delaney) successfully represented the Claimant and Third Party (together, “Teva”) in a revocation action of a patent of the Defendant “Grunenthal”. The patent in issue related to a formulation of testosterone undecanoate with castor oil and benzyl benzoate for the treatment of low testosterone levels in men, a condition […]